Christopher McDevitt
banner
camcdevitt.bsky.social
Christopher McDevitt
@camcdevitt.bsky.social
Scientist | Group Leader @mcdevittlab.bsky.social | Teaching & Research | Interested in Bacterial Infectious Diseases and Metals in Biology | Opinions are my own | He/Him
Proud #supervisor announcements! Congratulations to two of my brilliant PhD students 🌟
🥳 Huge congrats to Salma Naleem for winning the University of Melbourne 3 Minute Thesis competition,
and Abigail Hartono for winning the Graduate Student Poster Award at the Doherty Symposium!
🔥 You’re both stars!
September 4, 2025 at 9:22 PM
Reposted by Christopher McDevitt
🗞️ New interview!
@camcdevitt.bsky.social and @ellacasale.bsky.social of @thedohertyinst.bsky.social spoke to The Australian Financial Review about developing PBT2, a CARB-X-supported oral therapeutic that aims to restore the activity of antibiotics used to treat CABP. 🧪 #IDSky
🔗 bit.ly/45j832Q
Antibiotic resistance kills millions. These Australians have an answer
Investment in research has stalled, which means scientists are struggling to work on solutions for a serious global health issue.
bit.ly
August 20, 2025 at 1:43 PM
The costs of #antimicrobial resistance 🦠 continue to rise 📈. The Center for Global Development reports that by 2050 #AMR could shrink the global economy by US$1.7T.
Improving treatments and funding development of new antimicrobials 💊 could save millions of lives and billions in healthcare costs.
Forecasting the Fallout from AMR: Economic Impacts of Antimicrobial Resistance in Humans
Antimicrobial resistance (AMR) is a growing global health crisis that threatens to undo decades of progress in medicine. This tool allows you to explore the potential impact of different interventions...
www.cgdev.org
July 20, 2025 at 9:31 PM
Reposted by Christopher McDevitt
"Closure of the Fleming Fund risks undermining UK leadership on AMR." BSAC is seeking urgent clarification from the Government regarding the UK’s future leadership on antimicrobial resistance (#AMR), following reports that the Fleming Fund – the UK’s flagship global AMR programme – is set to close.
Closure of the Fleming Fund risks undermining UK leadership on AMR - The British Society for Antimicrobial Chemotherapy
bsac.org.uk
July 16, 2025 at 11:56 AM
Reposted by Christopher McDevitt
Hello, it’s lovely to be here. I’m so glad to share with you insights for leaders about cultivating inner and outer change. Please enjoy, and let me know what’s resonating for you! ✨ commaleadership.com/leadership-i...
Comma Leadership
Leadership coaching and facilitation with Dr Katy McDevitt – a specialist in development for leaders navigating complexity
commaleadership.com
June 1, 2025 at 12:28 AM
Congratulations 👏 to Matt Giles for representing @mcdevittlab.bsky.social and the Moraes group at the CanBIC-9 conference. A great presentation sharing his recent work on the #zinc uptake pathways in the #AMR bacterial pathogen 🦠 #Klebsiella pneumoniae.
May 23, 2025 at 3:13 PM
Excited to announce a funded #PhD project with my amazing colleagues Jeff Harmer and Evelyne Deplazes (Uni of Queensland). This collaborative project uses #biochemistry 🧪, advanced spectroscopy, and computational approaches 🖥️ to study a #zinc export system in a priority pathogen 🦠. Find out more at:
Harnessing structural insights into bacterial zinc efflux for new human therapeutics
study.uq.edu.au
April 29, 2025 at 11:50 PM
Reposted by Christopher McDevitt
Antimicrobial Resistance #AMR is a term most people have never heard of before yet it's a global health crisis

Our charity, #theAMRnarrative has created a 90-second explainer video to help you grasp the basics

youtu.be/S_0XQ5LhA6o?...

#AntibioticResistance
#AntimicrobialResistance #GlobalHealth
What is Antimicrobial Resistance (AMR)? - The AMR Narrative
YouTube video by The AMR Narrative
youtu.be
December 3, 2024 at 2:45 AM
Reposted by Christopher McDevitt
Congratulations to @camcdevitt.bsky.social @ellacasale.bsky.social and @blisscunningham.bsky.social for progressing in the CSIRO ON Innovation program to the ON Core stage. Great insights, advice and support on how to bring new #biomedical #AMR #technology to patients.
wp.csiro.au/oncore/
- ON Core
20 February, 2025 | Brisbane Connecting Australia’s deep tech community   ON Core, powered by the ON Innovation Program, is […]
wp.csiro.au
February 19, 2025 at 11:28 PM
Reposted by Christopher McDevitt
CARB-X is excited to join Bluesky! As a global public-private partnership addressing the rising threat of drug-resistant bacteria and #AMR, we look forward to engaging with our audience on Bluesky. Learn more about CARB-X below.
January 27, 2025 at 2:00 PM
Hello world 🌏
The @mcdevittlab.bsky.social team 🧑‍🔬👩‍🔬👨‍🔬 and I will be posting updates here and on LinkedIn going forward as we depart Twitter/X.
We look forward to sharing our exciting 🧪🔬🦠🧫 work on #biometals, #infection, #bacteriology, #AMR, and #antibiotic development with this community.
January 12, 2025 at 9:11 PM